BACKGROUND: The objective of the study was to evaluate the prognostic and therapeutic implications of an initial positive frozen section margin that was revised until negative (microscopic tumor cut-through), and to analyze the influence of microscopic margin status on oral carcinoma control. METHODS: The approach in our investigation was through a retrospective review of patients treated with primary surgery, with frozen section margin control in oral carcinoma. Inclusion criteria included availability of frozen and permanent section histology reports of resection margins and negative final resection margins. RESULTS: Of 547 patients studied, 175 received adjuvant radiation. Local and regional control and disease-specific survival rates were 81.6%, 78.4%, and 76.3%, respectively. Tumor cut-through and pathologic nodal (pN) stage had an independently adverse effect on local control. Tumor cut-through adversely affected cancer control and survival, but this effect diminished significantly in the absence of regional disease. CONCLUSIONS: Microscopic tumor cut-through revised to negative margins is a powerful prognosticator that is observed only when regional disease is also present. The value of adjuvant therapeutic regimens is questionable in patients with microscopic tumor cut-through, revised to negative margins, and with no regional disease.
BACKGROUND: The objective of the study was to evaluate the prognostic and therapeutic implications of an initial positive frozen section margin that was revised until negative (microscopic tumor cut-through), and to analyze the influence of microscopic margin status on oral carcinoma control. METHODS: The approach in our investigation was through a retrospective review of patients treated with primary surgery, with frozen section margin control in oral carcinoma. Inclusion criteria included availability of frozen and permanent section histology reports of resection margins and negative final resection margins. RESULTS: Of 547 patients studied, 175 received adjuvant radiation. Local and regional control and disease-specific survival rates were 81.6%, 78.4%, and 76.3%, respectively. Tumor cut-through and pathologic nodal (pN) stage had an independently adverse effect on local control. Tumor cut-through adversely affected cancer control and survival, but this effect diminished significantly in the absence of regional disease. CONCLUSIONS: Microscopic tumor cut-through revised to negative margins is a powerful prognosticator that is observed only when regional disease is also present. The value of adjuvant therapeutic regimens is questionable in patients with microscopic tumor cut-through, revised to negative margins, and with no regional disease.
Authors: B C Yoon; M D Bulbul; P M Sadow; W C Faquin; H D Curtin; M A Varvares; A F Juliano Journal: AJNR Am J Neuroradiol Date: 2020-06-18 Impact factor: 3.825
Authors: Patrick Tassone; Corey Savard; Michael C Topf; William Keane; Adam Luginbuhl; Joseph Curry; David Cognetti Journal: JAMA Otolaryngol Head Neck Surg Date: 2018-11-01 Impact factor: 6.223
Authors: Mark W Kubik; Shaum Sridharan; Mark A Varvares; Dan P Zandberg; Heath D Skinner; Raja R Seethala; Simion I Chiosea Journal: Head Neck Pathol Date: 2020-03-02
Authors: G Tirelli; S Zacchigna; F Boscolo Nata; E Quatela; R Di Lenarda; M Piovesana Journal: Eur Arch Otorhinolaryngol Date: 2016-08-04 Impact factor: 2.503
Authors: Jessica H Maxwell; Lester D R Thompson; Margaret S Brandwein-Gensler; Bernhard G Weiss; Martin Canis; Bibianna Purgina; Arpan V Prabhu; Chi Lai; Yongli Shuai; William R Carroll; Anthony Morlandt; Umamaheswar Duvvuri; Seungwon Kim; Jonas T Johnson; Robert L Ferris; Raja Seethala; Simion I Chiosea Journal: JAMA Otolaryngol Head Neck Surg Date: 2015-12 Impact factor: 6.223
Authors: Arpan V Prabhu; Charles D Sturgis; Chi Lai; Jessica H Maxwell; Mihai Merzianu; Juan C Hernandez-Prera; Bibianna Purgina; Lester D R Thompson; Madalina Tuluc; Xiu Yang; Raja R Seethala; Robert L Ferris; Simion I Chiosea Journal: Oral Oncol Date: 2017-11-01 Impact factor: 5.337
Authors: Michael M Li; Sidharth V Puram; Dustin A Silverman; Matthew O Old; James W Rocco; Stephen Y Kang Journal: Ann Surg Oncol Date: 2019-08-05 Impact factor: 5.344
Authors: P Horwich; C MacKay; M Bullock; S M Taylor; R Hart; J Trites; L Geldenhuys; B Williams; M H Rigby Journal: J Otolaryngol Head Neck Surg Date: 2021-06-21